BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8873298)

  • 21. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
    Musco S; Ruekert L; Myers J; Anderson D; Welling M; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(4):336-343. PubMed ID: 31205194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotic and Bipolar Disorders: Antipsychotic Drugs.
    Holder SD; Edmunds AL; Morgan S
    FP Essent; 2017 Apr; 455():23-29. PubMed ID: 28437058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movement disorders associated with atypical antipsychotic drugs.
    Caroff SN; Mann SC; Campbell EC; Sullivan KA
    J Clin Psychiatry; 2002; 63 Suppl 4():12-9. PubMed ID: 11913670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
    Rodnitzky RL; Keyser DL
    Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A protocol for the diagnosis and treatment of extrapyramidal symptoms of neuroleptic drugs.
    Bickal T
    Nurse Pract; 1987 Jan; 12(1):25, 29, 32 passim. PubMed ID: 2880325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics.
    Barnes TR; McPhillips MA
    Br J Psychiatry Suppl; 1999; (38):34-43. PubMed ID: 10884898
    [No Abstract]   [Full Text] [Related]  

  • 31. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects.
    Jafari S; Fernandez-Enright F; Huang XF
    J Neurochem; 2012 Feb; 120(3):371-84. PubMed ID: 22103329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs.
    Gualtieri TC; Barnhill J; McGinsey J; Schell D
    J Am Acad Child Psychiatry; 1980; 19(3):491-510. PubMed ID: 6106027
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 40. Tardive dyskinesia in older patients.
    Jeste DV
    J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.